Skip to main content

Table 2 Patients’ basal and operative characteristics

From: Impact of intra-operative cell salvage on blood coagulation in high-bleeding-risk patients undergoing cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial

Variable

Group CS (n = 53)

Group C (n = 50)

P value

Age (years)

50.42 (15.43)

52.53 (15.65)

0.549

 >70

12 (22.64)

13 (26.00)

0.691

Male

27 (50.94)

24 (48.00)

0.765

BSA

1.73 (0.14)

1.73 (0.13)

0.946

 <1.6 m2

5 (9.43)

4 (8.00)

1.000

Surgery type

  

0.922

 Multiple valve

36 (67.92)

33 (66.00)

 

 Bentall

8 (15.09)

7 (20.00)

 

 Reoperations

9 (16.98)

10 (14.00)

 

Preoperative complication

 Renal dysfunction

19 (35.84)

18 (36.00)

0.987

 Liver insufficiency

9 (16.98)

7 (14.00)

0.676

 Coagulation disorders

15 (28.30)

13 (26.00)

0.793

 HB levels lower (<13 g/dL in male or <12 g/dL in female)

21 (39.62)

23 (46.00)

0.513

17 (32.08)

18 (36.00)

0.674

 PLT levels lower (<50 × 109/L) intake of aspirin or clopidogrel

12 (22.53)

11 (22.00)

0.938

CPB time (min)

136.05 (36.82)

126.65 (25.63)

0.342

Surgical time (min)

302.56 (28.02)

295.94 (22.02)

0.220

Tracheal intubation time (hour)

13.92 (10.83)

13.15 (3.62)

0.434

Length of ICU stay (hour)

19.42 (4.43)

20.42 (4.16)

0.099

Length of hospital stay (day)

22.56 (4.23)

23.38 (4.54)

0.206

Residual blood in CPB circuit

853.67 (50.46)

837.22 (92.53)

0.200

Intra-operative blood loss (mL)

1640.96 (87.73)

1609.03 (137.91)

0.072

MTD (mL)

 In 6 h

333.02 (147.14)

295.03 (152.82)

0.301

 In 24 h

657.78 (272.94)

591.96 (171.53)

0.071

Intra-operative heparin dose (mg)

244.63 (49.82)

241.06 (49.35)

0.778

Intra-operative protamine dose (mg)

428.37 (92.83)

417.36 (92.02)

0.478

  1. Data are presented as mean (SD) or number (percentage)
  2. MTD mediastinal tube drainage, patients with resternotomy were not calculated